Edesa Biotech
EDSA
17 hedge funds and large institutions have $350K invested in Edesa Biotech in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
201% more capital inflows, than outflows
Capital inflows: $164K | Capital outflows: $54.4K
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
1.02% more ownership
Funds ownership: 4.96% → 5.98% (+1%)
6% less funds holding
Funds holding: 18 → 17 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$114K |
| 2 |
Two Sigma Securities
New York
|
+$42.6K |
| 3 |
Tower Research Capital (TRC)
New York
|
+$6.74K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$220 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$75 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$50.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.8K |
| 3 |
AW
Avion Wealth
The Woodlands,
Texas
|
-$1K |
| 4 |
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$85 |
| 5 |
Morgan Stanley
New York
|
-$39 |
EDSA Hedge Fund Activity: Q4 2024 in Review
17 of the 7,623 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2024, worth a combined $350K — down 51% from $718K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of EDSA and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $114K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $50.4K sold.
- 17 institutional investors held Edesa Biotech (EDSA) as of Q4 2024, down from 18 in Q3 2024.
- Funds reported $350K of Edesa Biotech stock for Q4 2024, down 51% quarter-over-quarter.
- 3 funds opened new Edesa Biotech positions in Q4 2024 and 4 closed out, a net change of -1 holder.
- The largest Edesa Biotech buyer in Q4 2024 was Citadel Advisors, an estimated $114K added.
- The largest Edesa Biotech seller in Q4 2024 was Dimensional Fund Advisors, an estimated $50.4K sold.
Based on aggregated 13F filings for Q4 2024.